Patients Without a Rheumatic Disease Diagnosis in a Pediatric Rheumatology Unit: Retrospective Analysis and Comparison Between Pre-pandemic and Pandemic Periods

Yıl: 2023 Cilt: 58 Sayı: 1 Sayfa Aralığı: 49 - 55 Metin Dili: İngilizce DOI: 10.5152/TurkArchPediatr.2022.22192 İndeks Tarihi: 18-05-2023

Patients Without a Rheumatic Disease Diagnosis in a Pediatric Rheumatology Unit: Retrospective Analysis and Comparison Between Pre-pandemic and Pandemic Periods

Öz:
Objective: Children with suspicious complaints of rheumatic diseases are generally referred to a pediatric rheumatologist. We aimed to evaluate the profile of patients referred to the pedi- atric rheumatology unit and were not diagnosed with a rheumatic disease and to assess the impact of the coronavirus disease-2019 pandemic on referral complaints. Materials and Methods: All new outpatients who applied to the pediatric rheumatology depart- ment between March 2019 and February 2021 and were not diagnosed with rheumatic disease were included. We also compared the frequency of admission symptoms during the pre-pan- demic (March 2019-February 2020) and pandemic periods (March 2020-February 2021). Results: A total of 1089 patients without a rheumatic disease diagnosis (568 female, 52.2%; median age 10.0 years) were included in this study. The most common complaint for refer- ral was prolonged or recurrent fevers (13.4%) followed by anti-nuclear antibody positivity (13.1%), arthralgia (13.0%), skin findings (7.5%), and the presence of heterozygous mutations in the Mediterranean fever gene (6.9%). During the pandemic year, the number of patients referred for back pain increased significantly (P = .028). A total of 682 of 1089 patients were consulted from other departments in our center (62.6%). Of these, the most frequent consulta- tion request was from general pediatrics (43.6%). The rheumatic disease was excluded in 11.3% of the patients. Conclusion: Prolonged or recurrent fever and anti-nuclear antibody positivity were the most frequent complaints of referrals to a pediatric rheumatology unit in patients who did not have a rheumatic disease. The rate of back pain was more common in children during the pandemic period.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Schaller JG. The history of pediatric rheumatology. Pediatr Res. 2005;58(5):997-1007. [CrossRef]
  • 2. Huemer C, Huemer M, Dorner T, et al. Incidence of pediatric rheu- matic diseases in a regional population in Austria. J Rheumatol. 2001;28(9):2116-2119.
  • 3. Adrovic A, Kasapcopur O. Pediatric rheumatology in Turkey. Rheu- matol Int. 2019;39(3):431-440. [CrossRef]
  • 4. Malleson PN, Fung MY, Rosenberg AM. The incidence of pediatric rheumatic diseases: results from the Canadian Pediatric Rheuma- tology Association Disease Registry. J Rheumatol. 1996;23(11):1981-1987.
  • 5. Karadağ ŞG, Sönmez HE, Tanatar A, Çakmak F, Çakan M, Ayaz NA. Profile of new referrals to a single pediatric rheumatology center in Turkey. Rheumatol Int. 2020;40(2):313-321. [CrossRef]
  • 6. Hashkes PJ. Profile of a pediatric rheumatology practice in Israel. Clin Exp Rheumatol. 2003;21(1):123-128.
  • 7. Rosenberg AM. Longitudinal analysis of a pediatric rheumatology clinic population. J Rheumatol. 2005;32(10):1992-2001.
  • 8. Tallen G, Bielack S, Henze G, et al. Musculoskeletal pain: a new algorithm for differential diagnosis of a cardinal symptom in pedi- atrics. Klin Padiatr. 2014;226(2):86-98. [CrossRef]
  • 9. de Inocencio J. Musculoskeletal pain in primary pediatric care: analysis of 1000 consecutive general pediatric clinic visits. Pediat- rics. 1998;102(6):E63. [CrossRef]
  • 10. Sandborg CI, Wallace CA. Position statement of the American Col- lege of Rheumatology regarding referral of children and adoles- cents to pediatric rheumatologists. Executive Committee of the American College of Rheumatology Pediatric Section. Arthritis Care Res. 1999;12(1):48-51. [CrossRef]
  • 11. Harapan H, Itoh N, Yufika A, et al. Coronavirus disease 2019 (COVID-19): a literature review. J Infect Public Health. 2020;13(5):667-673. [CrossRef]
  • 12. Atangana A, Araz Sİ. Mathematical model of COVID-19 spread in Turkey and South Africa: theory, methods, and applications. Adv Differ Equ. 2020;2020:1.
  • 13. Batu ED, Lamot L, Sag E, Ozen S, Uziel Y. How the COVID-19 pan- demic has influenced pediatric rheumatology practice: results of a global, cross-sectional, online survey. Semin Arthritis Rheum. 2020;50(6):1262-1268. [CrossRef]
  • 14. Wong K, Farooq Alam Shah MUFA, Khurshid M, Ullah I, Tahir MJ, Yousaf Z. COVID-19 associated vasculitis: a systematic review of case reports and case series. Ann Med Surg (Lond). 2022;74:103249. [CrossRef]
  • 15. Fang Y, Aravamudan VM, Sridharan GK, et al. Kawasaki like illness due to COVID-19: a review of the literature. J Infect Dev Ctries . 2021;15(5):630-638. [CrossRef]
  • 16. Şener S, Başaran Ö, Laçinel Gürlevik S, et al. Challenges in diag- nosing COVID-19 related disease in pediatric patients with rheu- matic disease. Mod Rheumatol. 2022;32:1108-1113.
  • 17. Demir S, Bilginer Y. COVID-19 pandemic from pediatric rheuma- tologists perspective. Turk Arch Pediatr. 2022;57(4):375-376. [CrossRef]
  • 18. Batu ED, Sener S, Ozen S. COVID-19 associated pediatric vasculi- tis: a systematic review and detailed analysis of the pathogenesis. Semin Arthritis Rheum. 2022;55:152047. [CrossRef]
  • 19. Kaya Akca U, Atalay E, Cuceoglu MK, et al. Impact of the COVID-19 pandemic on the frequency of the pediatric rheumatic diseases. Rheumatol Int. 2022;42(1):51-57. [CrossRef]
  • 20. Bowyer S, Roettcher P. Pediatric rheumatology clinic populations in the United States: results of a 3 year survey. Pediatric Rheuma- tology Database Research Group. J Rheumatol. 1996;23(11):1968-1974.
  • 21. Arkachaisri T, Tang SP, Daengsuwan T, et al. Paediatric rheuma- tology clinic population in Southeast Asia: are we different? Rheu- matology (Oxford). 2017;56(3):390-398. [CrossRef]
  • 22. Martorana D, Bonatti F, Mozzoni P, Vaglio A, Percesepe A. Mono- genic autoinflammatory diseases with Mendelian inheritance: genes, mutations, and genotype/phenotype correlations. Front Immunol. 2017;8:344. [CrossRef]
  • 23. Yilmaz E, Ozen S, Balcı B, et al. Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet. 2001;9(7):553-555. [CrossRef]
  • 24. Batu ED, Basaran O, Bilginer Y, Ozen S. Familial Mediterranean fever: how to interpret genetic results? How to treat? A quarter of a century after the association with the MEFV gene. Curr Rheuma- tol Rep. How to Treat. 2022;24(6):206-212. [CrossRef]
  • 25. Sönmez HE, Batu ED, Bilginer Y, Özen S. Discontinuing colchicine in symptomatic carriers for MEFV (Mediterranean FeVer) variants. Clin Rheumatol. 2017;36(2):421-425. [CrossRef]
  • 26. Lachmann HJ, Şengül B, Yavuzşen TU, et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford). 2006;45(6):746-750. [CrossRef]
  • 27. Tunca M, Kirkali G, Soytürk M, Akar S, Pepys MB, Hawkins PN. Acute phase response and evolution of familial Mediterranean fever. Lancet. 1999;353(9162):1415. [CrossRef]
  • 28. Correll CK, Spector LG, Zhang L, Binstadt BA, Vehe RK. Barriers and alternatives to pediatric rheumatology referrals: survey of general pediatricians in the United States. Pediatr Rheumatol Online J. 2015;13:32. [CrossRef]
  • 29. Satoh M, Vázquez-Del Mercado M, Chan EK. Clinical interpreta- tion of antinuclear antibody tests in systemic rheumatic diseases. Mod Rheumatol. 2009;19(3):219-228. [CrossRef]
  • 30. Batu ED, Akca UK, Kısaarslan AP, et al. The performances of the ACR 1997, SLICC 2012, and EULAR/ACR 2019 classification criteria in pediatric systemic lupus erythematosus. J Rheumatol. 2021;48(6):907-914. [CrossRef]
  • 31. Grygiel-Górniak B, Rogacka N, Puszczewicz M. Antinuclear antibod- ies in healthy people and non-rheumatic diseases–diagnostic and clinical implications. Reumatologia. 2018;56(4):243-248. [CrossRef]
  • 32. Haslak F, Yildiz M, Altun I, et al. Anti-nuclear antibody testing in children: how much is really necessary? Pediatr Int. 2021;63(9):1020- 1025. [CrossRef]
  • 33. Wananukul S, Voramethkul W, Kaewopas Y, Hanvivatvong O. Prev- alence of positive antinuclear antibodies in healthy children. Asian Pac J Allergy Immunol. 2005;23(2-3):153-157.
  • 34. Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology classifi- cation criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151-1159. [CrossRef]
  • 35. Mariz HA, Sato EI, Barbosa SH, Rodrigues SH, Dellavance A, Andrade LE. Pattern on the antinuclear antibody–HEp-2 test is a critical parameter for discriminating antinuclear antibody–posi- tive healthy individuals and patients with autoimmune rheumatic diseases. Arthritis Rheum. 2011;63(1):191-200. [CrossRef]
  • 36. Abeles AM, Abeles M. The clinical utility of a positive antinuclear antibody test result. Am J Med. 2013;126(4):342-348. [CrossRef]
  • 37. Sen ES, Clarke SL, Ramanan AV. The child with joint pain in pri- mary care. Best Pract Res Clin Rheumatol. 2014;28(6):888-906. [CrossRef]
  • 38. Yener GO, Tekin ZE, Girişgen İ, Çetin EN, Akdağ B, Yüksel S. Juvenile idiopathic arthritis in a center in the western Anatolia region in Turkey. Turk Pediatr Ars. 2020;55(2):157-165. [CrossRef]
  • 39. Sönmez HE, Karadağ ŞG, Aktay ayaz N. Musculoskeletal com- plaints: when should we consult a pediatric rheumatologist? Mus- culoskeletal complaints in children. The J Pediatr Acad. 2022;3(1):6-10. [CrossRef]
  • 40. Batu ED, Özen S. Implications of COVID-19 in pediatric rheumatol- ogy. Rheumatol Int. 2020;40(8):1193-1213. [CrossRef]
  • 41. Silva DR, Werneck AO, Malta DC, et al. Changes in movement behaviors and back pain during the first wave of the COVID-19 pandemic in Brazil. Braz J Phys Ther. 2021;25(6):819-825. [CrossRef]
  • 42. Oflu A, Bükülmez A, Elmas E, Tahta EG, Çeleğen M. Comparison of screen time and digital gaming habits of Turkish children before and during the coronavirus disease 2019 pandemic. Turk Arch Pediatr. 2021;56(1):22-26. [CrossRef]
  • 43. Grech S, Borg JN, Cuschieri S. Back pain: an aftermath of Covid-19 pandemic? A Malta perspective. Musculoskelet Care. 2022;20(1):145-150. [CrossRef]
  • 44. Degiorgio S, Grech N, Dimech YM, Xuereb J, Grech V. Significant reduction in pediatric, population-based hospital admissions due to COVID-19 in Malta. Turk Arch Pediatr. 2022;57(1):87-92. [CrossRef]
APA Kaya Akca Ü, Tanalı G, Batu E, Atalay E, KASAP CUCEOGLU M, Şener S, balık z, BAYINDIR Y, Aliyev E, BAŞARAN ö, Bilginer Y, Ozen S (2023). Patients Without a Rheumatic Disease Diagnosis in a Pediatric Rheumatology Unit: Retrospective Analysis and Comparison Between Pre-pandemic and Pandemic Periods. , 49 - 55. 10.5152/TurkArchPediatr.2022.22192
Chicago Kaya Akca Ümmüşen,Tanalı Gizem,Batu Ezgi Deniz,Atalay ERDAL,KASAP CUCEOGLU MUSERREF,Şener Seher,balık zeynep,BAYINDIR YAGMUR,Aliyev Emil,BAŞARAN özge,Bilginer Yelda,Ozen Seza Patients Without a Rheumatic Disease Diagnosis in a Pediatric Rheumatology Unit: Retrospective Analysis and Comparison Between Pre-pandemic and Pandemic Periods. (2023): 49 - 55. 10.5152/TurkArchPediatr.2022.22192
MLA Kaya Akca Ümmüşen,Tanalı Gizem,Batu Ezgi Deniz,Atalay ERDAL,KASAP CUCEOGLU MUSERREF,Şener Seher,balık zeynep,BAYINDIR YAGMUR,Aliyev Emil,BAŞARAN özge,Bilginer Yelda,Ozen Seza Patients Without a Rheumatic Disease Diagnosis in a Pediatric Rheumatology Unit: Retrospective Analysis and Comparison Between Pre-pandemic and Pandemic Periods. , 2023, ss.49 - 55. 10.5152/TurkArchPediatr.2022.22192
AMA Kaya Akca Ü,Tanalı G,Batu E,Atalay E,KASAP CUCEOGLU M,Şener S,balık z,BAYINDIR Y,Aliyev E,BAŞARAN ö,Bilginer Y,Ozen S Patients Without a Rheumatic Disease Diagnosis in a Pediatric Rheumatology Unit: Retrospective Analysis and Comparison Between Pre-pandemic and Pandemic Periods. . 2023; 49 - 55. 10.5152/TurkArchPediatr.2022.22192
Vancouver Kaya Akca Ü,Tanalı G,Batu E,Atalay E,KASAP CUCEOGLU M,Şener S,balık z,BAYINDIR Y,Aliyev E,BAŞARAN ö,Bilginer Y,Ozen S Patients Without a Rheumatic Disease Diagnosis in a Pediatric Rheumatology Unit: Retrospective Analysis and Comparison Between Pre-pandemic and Pandemic Periods. . 2023; 49 - 55. 10.5152/TurkArchPediatr.2022.22192
IEEE Kaya Akca Ü,Tanalı G,Batu E,Atalay E,KASAP CUCEOGLU M,Şener S,balık z,BAYINDIR Y,Aliyev E,BAŞARAN ö,Bilginer Y,Ozen S "Patients Without a Rheumatic Disease Diagnosis in a Pediatric Rheumatology Unit: Retrospective Analysis and Comparison Between Pre-pandemic and Pandemic Periods." , ss.49 - 55, 2023. 10.5152/TurkArchPediatr.2022.22192
ISNAD Kaya Akca, Ümmüşen vd. "Patients Without a Rheumatic Disease Diagnosis in a Pediatric Rheumatology Unit: Retrospective Analysis and Comparison Between Pre-pandemic and Pandemic Periods". (2023), 49-55. https://doi.org/10.5152/TurkArchPediatr.2022.22192
APA Kaya Akca Ü, Tanalı G, Batu E, Atalay E, KASAP CUCEOGLU M, Şener S, balık z, BAYINDIR Y, Aliyev E, BAŞARAN ö, Bilginer Y, Ozen S (2023). Patients Without a Rheumatic Disease Diagnosis in a Pediatric Rheumatology Unit: Retrospective Analysis and Comparison Between Pre-pandemic and Pandemic Periods. Turkish archives of pediatrics (Online), 58(1), 49 - 55. 10.5152/TurkArchPediatr.2022.22192
Chicago Kaya Akca Ümmüşen,Tanalı Gizem,Batu Ezgi Deniz,Atalay ERDAL,KASAP CUCEOGLU MUSERREF,Şener Seher,balık zeynep,BAYINDIR YAGMUR,Aliyev Emil,BAŞARAN özge,Bilginer Yelda,Ozen Seza Patients Without a Rheumatic Disease Diagnosis in a Pediatric Rheumatology Unit: Retrospective Analysis and Comparison Between Pre-pandemic and Pandemic Periods. Turkish archives of pediatrics (Online) 58, no.1 (2023): 49 - 55. 10.5152/TurkArchPediatr.2022.22192
MLA Kaya Akca Ümmüşen,Tanalı Gizem,Batu Ezgi Deniz,Atalay ERDAL,KASAP CUCEOGLU MUSERREF,Şener Seher,balık zeynep,BAYINDIR YAGMUR,Aliyev Emil,BAŞARAN özge,Bilginer Yelda,Ozen Seza Patients Without a Rheumatic Disease Diagnosis in a Pediatric Rheumatology Unit: Retrospective Analysis and Comparison Between Pre-pandemic and Pandemic Periods. Turkish archives of pediatrics (Online), vol.58, no.1, 2023, ss.49 - 55. 10.5152/TurkArchPediatr.2022.22192
AMA Kaya Akca Ü,Tanalı G,Batu E,Atalay E,KASAP CUCEOGLU M,Şener S,balık z,BAYINDIR Y,Aliyev E,BAŞARAN ö,Bilginer Y,Ozen S Patients Without a Rheumatic Disease Diagnosis in a Pediatric Rheumatology Unit: Retrospective Analysis and Comparison Between Pre-pandemic and Pandemic Periods. Turkish archives of pediatrics (Online). 2023; 58(1): 49 - 55. 10.5152/TurkArchPediatr.2022.22192
Vancouver Kaya Akca Ü,Tanalı G,Batu E,Atalay E,KASAP CUCEOGLU M,Şener S,balık z,BAYINDIR Y,Aliyev E,BAŞARAN ö,Bilginer Y,Ozen S Patients Without a Rheumatic Disease Diagnosis in a Pediatric Rheumatology Unit: Retrospective Analysis and Comparison Between Pre-pandemic and Pandemic Periods. Turkish archives of pediatrics (Online). 2023; 58(1): 49 - 55. 10.5152/TurkArchPediatr.2022.22192
IEEE Kaya Akca Ü,Tanalı G,Batu E,Atalay E,KASAP CUCEOGLU M,Şener S,balık z,BAYINDIR Y,Aliyev E,BAŞARAN ö,Bilginer Y,Ozen S "Patients Without a Rheumatic Disease Diagnosis in a Pediatric Rheumatology Unit: Retrospective Analysis and Comparison Between Pre-pandemic and Pandemic Periods." Turkish archives of pediatrics (Online), 58, ss.49 - 55, 2023. 10.5152/TurkArchPediatr.2022.22192
ISNAD Kaya Akca, Ümmüşen vd. "Patients Without a Rheumatic Disease Diagnosis in a Pediatric Rheumatology Unit: Retrospective Analysis and Comparison Between Pre-pandemic and Pandemic Periods". Turkish archives of pediatrics (Online) 58/1 (2023), 49-55. https://doi.org/10.5152/TurkArchPediatr.2022.22192